Under the auspices of the Ministry of Health and Welfare of Japan and the Japanese Pharmaceutical Manufacturer Association, a collaborative study of the mouse lymphoma assay (MLA) was conducted by 42 Japanese laboratories and seven overseas laboratories to clarify the performance of the MLA for the detection of in vitro clastogens and spindle poisons. Twenty-one chemicals that were positive in in vitro chromosomal aberration assays (CA) but negative in bacterial reverse mutation assays (BRM) were examined by the MLA using the microweU method. All chemicals were coded, and each chemical was tested by two or three laboratories. Positive responses were obtained with 14 chemicals: mitomycin C (an internal positive control), arsenic trioxide, cadmium sulphate, chlorendic acid, cytosine arabinoside, diethylstilbestrol, eugenol, 5-fluorouracil, griseofulvin, hexamethyl phosphoramide, hydroxyurea, methotrexate, monocrotaline and pentachloroethane. Two chemicals (benzene and chlorodibromomethane) showed positive responses in one of two laboratories and were judged probably positive chemicals. Three chemicals (bromodichloromethane, isophorone and tetrachloroethane) were inconclusive because of a marginal response in one laboratory and a negative response in the other. Urethane was judged probably negative because two laboratories out of three showed clear negative responses. Dideoxycytidine (DDC) was a clear negative chemical in this study. The present results showed that 75.0% of the test chemicals (15/20, excluding mitomycin C) were positive, 15.0% (3/20) were inconclusive, and 10.0% (2/20) were negative. This suggests that the MLA may detect a majority of C A-positive chemicals. The inconclusive chemicals, however, are critical for the judgement of the MLA potential to detect clastogens. The finding that DDC was clearly negative suggests that the MLA may not be able to detect some clastogens. To clarify these issues, we began the second phase of the collaborative study with other BRMnegative and CA-positive chemicals.
Introduction
It is generally agreed that no single genotoxicity test is capable of detecting all genotoxic agents, and a battery of genotoxicity tests is required. The make-up of the battery, however, differs between countries and organizations. In Japan, the minimum battery consists of a bacterial reverse mutation assay (BRM), an in vitro chromosome aberration assay (CA) and an in vivo rodent micronucleus assay (MN) (Ministry of Health and Welfare, 1990) . The minimum battery for US regulatory agencies is composed of a BRM, a mouse lymphoma assay (MLA) and an in vivo cytogenetic test (CG; a metaphase analysis or MN) (Dearfield et ai, 1991) , and that of the EU is a BRM, a CA, an in vitro mammalian cell gene mutation assay (MCGM) and a CG (CEC/EU, 1989) .
In an effort to harmonize the practice of genotoxicity testing internationally, the minimum battery of genotoxicity tests was discussed by the Expert Working Group on Genotoxicity at the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. A pivotal issue in harmonization is whether a MCGM assay, in particular the MLA, is needed in the minimum battery and whether the MLA can be an alternative to the CA. The MLA has been regarded as the most sensitive in vitro mammalian cell mutation assay that is capable of detecting clastogens as well as mutagens (Clive et al., 1979) , resulting in the recommendation to include the MLA in the minimum test battery. On the other hand, it was suggested that the MLA is too sensitive and often unreliable when marginal or weak positive results are associated with excessive cytotoxicity. Thus it has been considered that the MLA may not be suitable for the minimum test battery.
One of the most critical issues is to understand how well the MLA can detect in vitro clastogens and spindle poisons, that is, how many CA-positive chemicals can be ranked as positive in the MLA. For this aim, an international collaborative study for the MLA was conducted under the auspices of the Ministry of Health and Welfare of Japan and the Japanese Pharmaceutical Manufacturer Association.
Materials and methods

Participants
Forty-two Japanese laboratories and seven overseas laboratories participated in this collaborative study, as shown in Table I . 
Cells
The mouse lymphoma L5178Y tk +/ " cell clone 3.7.2C, kindly supplied by Dr D.Chve (Burroughs Wellcome Co., Research Triangle Park, NC), was used.
Test chemicals
The test chemicals used were divided into three categories (Table II) . The first category included 14 chemicals that were ranked positive in the CA but negative in the BRM (Ishidate el at., 1988; Zeiger et at., 1990) . The second category included six chemicals that were ranked as MLA-positive but CA-negative by the NTP (Zeiger et at.. 1990) . The results of our own re-evaluation according to Japanese guidelines, however, indicated that those chemicals evoked positive responses in the CA according to the extensive protocol with CHL/IU cells (A.Matsuoka et at., submitted for publication), so we recognized them as CA-positive and tried to confirm the positive results in the MLA. The last category comprised mitomycin C, which was used as an internal positive control.
The test chemicals were coded until the completion of the study. Each chemical was tested by two or three laboratories to confirm the data and to evaluate interlaboratory variability. As positive controls, methyl melhanesulfonate (MMS) and cyclophosphamide (CP) were used in the absence and presence of S9 mix respectively.
Familiarization and technical transfer workshop
For all Japanese participants familiarization with the MLA was conducted with MMS before starting the main collaborative study with a coded chemical.
After performing at least one trial according to the protocol provided by the organizing committee, the technical transfer workshop took place at the Food and Drug Safety Center, Hatano Research Institute, Kanagawa, with the participation of a well-experienced researcher, Dr J.Clements (Coming Hazleton Ltd, UK).
Experimental method
The microwell method as described by Cole et at. (1983) was principally used because this method is well validated, free from agar-quality problems, and less subjective than the agar method for classifying large and small colonies. The cytotoxicity of the test chemical was determined by relative survival (RS) after 3 h treatment at concentrations up to 5000 Hg/ml with and without S9 mix, regardless of solubility. The highest concentration chosen was one with a 10-20^ RS. There was no perceived need to test concentrations >5000 ng/ml. Each experiment usually consisted of one solvent control, one positive control and at least three test chemical concentrations in duplicate cultures. As a rule, 2-fold serial dilutions were prepared from the highest concentration to obtain at least three graded concentration levels. Mutation experiment Cultures were exposed to the test chemical for 3 h, then cultured for 2 days before plating in 96-well microtiter plates at 2000 cells/well with tnfluorothymidine for mutant selection and at 1.6 cells/well for cell viability. The number of wells containing colonies was counted on day 12 after plating, and large and small colonies were scored. Mutation frequencies were analyzed by the statistical package generated in accordance with the UKEMS guidelines (Robinson el al., 1989) . This includes two procedures: pair-wise comparison of each treatment with the concurrent negative control and assessment of a linear trend of mutation frequencies with concentrations.
Criteria for lest acceptance
The acceptable ranges of mean absolute plating efficiency (PE) for solvent control were 60-140% for survival (PEO) and 70-130% for viability (PE2), based on the consensus agreements of MLA protocols discussed in the MLA Workshop at Portland, OR, 1994 (Clive et al., 1995 .
Final evaluation
To evaluate whether the MLA can detect CA-positive chemicals as well as the CA test, the organizing committee had predetermined that >90% of the CA-positive chemicals should be ranked as positive by the MLA, although ideally all MLA results should be identical with those of the CA.
Results and discussion
Forty-seven of the 49 laboratories participating this collaborative study produced a report. Sixteen chemicals were tested by 
352
two laboratories and five were tested by the three laboratories indicated as A, B or C (overseas laboratory) in Only 26.6% of the highest concentrations (25 experiments out of 94) fell into the desired range of 10-20% RS (Clive et al, 1995) . However, the highest concentrations in the other experiments were not very far from the defined range. Even in cases outside of the defined range, when severe cytotoxicity spontaneous mutation frequency in the solvent control of the present study were as follows: 135 ± 61X10" 6 (42-356X 10" 6 ) in the absence of S9 mix; 147 ± 66X10-6 (37-323X 10" 6 ) in the presence of S9 mix; and 141 ± 64X10" 6 (37-356 X10-6 ) overall. The UKEMS guideline and consensus agreement of the MLA protocol (Clive et al, 1995) proposed that duplicate cultures be required for the microwell method as a quality control. In the present study the data from duplicate cultures corresponded well, and very few showed appreciable heterogeneity (5/94; 5.3%). This indicated that the microwell method under the present protocol did not result in serious data discordance between cultures.
The summary of mutagenicity evaluation of each test chemical is given in Table ITJ . In the results column, when a response was significant in both the pair-wise comparison (in at least one concentration within the acceptable range) and the linear trend test, it is designated ' + '. When either the pairwise comparison or the linear trend test was significant, it is designated 'P' or 'L' respectively. When no significance was obtained in both procedures, it is designated '-'. Parentheses indicate that the experiment contains unacceptable PE0 and/ or PE2 for the solvent control. Considering the extent of response, interlaboratory differences and data acceptability, each chemical was classified into one of five categories: 'positive', 'probably positive', 'inconclusive', 'probably negative' and 'negative', as indicated below. Positive: positive responses were obtained with 14 chemicals (mitomycin C, arsenic trioxide, cadmium sulphate, chlorendic acid, cytosine arabinoside, diethylstilbestrol, eugenol, 5-fluorouracil, griseofulvin, hexamethyl phosphoramide, hydroxyurea, methotrexate, monocrotaline and pentachloroethane) (Figures 1-5 ).
Probably positive: two chemicals (benzene and chlorodibromomethane) evoked positive responses with S9 mix in only one laboratory ( Figure 6 ). The other laboratory's data were also positive, but the solvent control data fell into the unacceptable range. Based on the dose-dependent linear responses and significantly increased mutation frequencies, we judged these chemicals as probably positive. Inconclusive: two chemicals (bromodichloromethane and isophorone) evoked marginal dose-dependent responses in one laboratory and one chemical (tetrachloroethane) caused an abrupt increase in the mutation frequency at only one concentration in one laboratory ( Figure 7 ). As the other laboratories obtained negative results for these three chemicals, it was difficult to accept the above responses as biologically signific-
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ant. The chemicals are provisionally classified as inconclusive and will be re-examined in a second phase of the MLA collaborative study.
Probably negative: urethane was tested by three laboratories. Two laboratories showed clear negative results and one laboratory showed a positive response without S9 mix (Figure 8 ). Urethane was not cytotoxic even at 5000 |ig/ml in the first two laboratories. In the third, however, cytotoxicity accompanied by an increase in mutation frequency was observed, albeit not in the preliminary dose-finding test. Therefore, we judged it as probably negative. Urethane is known to be a clastogen, but its clastogenicity was detected only after 48 h of continuous treatment at an extremely high concentration (8000 ug/ml) (Ishidate, 1987) . Urethane might also be negative in the CA under nontoxic conditions similar to those of this study. Negative: dideoxycytidine was not cytotoxic at up to 5000 |ig/ ml and did not increase the mutation frequency under any conditions in either testing laboratory (Figure 8 ). Therefore, dideoxycytidine was identified as a clear negative chemical in this study. A positive response was obtained by others in the CA using cultured human lymphocytes and long continuous treatment without metabolic activation (Chetelat, 1987) . It is possible that a continuous treatment may be required to get a positive response in the MLA as well. Some chemicals such as a-naphthoquinoline, theophylline, and triamterene were reported as CA-positive by continuous treatment but not by pulse treatment (Ishidate, 1987) , and were thought to be negative in the MLA using the standard protocol. These chemicals are also being examined in a second phase of the MLA collaborative study.
An outward feature of the first phase results suggests that the MLA may detect a wide range of in vitro clastogens and spindle poisons. However, before we reach such a conclusion, we need more detailed comparative analyses, such as (i) what extent of clastogenic potential was reported for each test chemical; (ii) by what treatment condition was a positive result obtained; and (iii) whether the test chemical induced only polyploids or not. A detailed discussion of these points and an overall conclusion will be reported in a separate paper, which will include results from both the first and second phases of the collaborative study.
